-
June 13, 2008
Hair dye may boost lymphoma risk: study
NEW YORK (Reuters Health) - A new study suggests that use of hair dye may increase the risk of certain types of non-Hodgkin lymphoma (NHL), a blood cancer involving the lymph nodes.
-
March 21, 2008
Cephalon wins U.S. approval for leukemia drug
WASHINGTON (Reuters) - Cephalon Inc won U.S. approval to sell a chemotherapy drug to treat patients with a slow-growing type of leukemia, the company said on Thursday.
-
December 10, 2007
Experimental drug works in type of leukemia
NEW YORK (Reuters) - Cephalon Inc's experimental cancer drug Treanda was significantly more effective than a common chemotherapy agent in helping patients with chronic lymphocytic leukemia (CLL) who had not received prior treatment achieve remission, according to a late-stage study.
-
October 31, 2007
Loss of viral control tied to lymphoma risk
NEW YORK (Reuters Health) - Patients who have abnormal reactive blood patterns when exposed to Epstein-Barr virus appear to have an increased risk of lymphoma, according to European researchers.